Zobrazeno 1 - 10
of 16
pro vyhledávání: '"K J, Pandya"'
Autor:
J E, Olson, D, Neuberg, K J, Pandya, M P, Richter, L J, Solin, K W, Gilchrist, D C, Tormey, M, Veeder, G, Falkson
Publikováno v:
Cancer. 79(6)
The purpose of this study was to test the role of radiotherapy following total mastectomy, axillary dissection, and adjuvant systemic therapy in the management of operable locally advanced breast carcinoma.After undergoing mastectomy and axillary dis
Autor:
C. L. Loprinzi, J. A. Sloan, V. Stearns, B. Diekmann, P. J. Novotny, G. Kimmick, P. Gordon, K. J. Pandya, T. Guttuso Jr, S. Reddy
Publikováno v:
Journal of Clinical Oncology. 26:9537-9537
Publikováno v:
Journal of Clinical Oncology. 26:17036-17036
17036 Background: Tongue cancer is rare, yet the treatment of oral and base of tongue cancer represents one of the most challenging tasks to oncologists due to the vital importance of organ preservation. For locally advanced tumors, surgery is often
Publikováno v:
Journal of Clinical Oncology. 26:22085-22085
22085 Background: Excision repair cross-complementation 1 (ERCC1) is reported to be variably expressed in non-small-cell lung carcinomas (NSCLC), and to be a predictor of response to platinum-based...
Publikováno v:
Progress in clinical and biological research. 339
Autor:
K. J. Pandya, S. C. Phan
Publikováno v:
Journal of Clinical Oncology. 23:3138-3138
3138 Background: MGd is a novel anti-neoplastic agent that targets tumors and generates reactive oxygen species (ROS) by redox cycling. Pre-clinical models show that MGd enhances the cytotoxic acti...
Autor:
K. J. Pandya, J. Roscoe, E. Pajon, P. J. Kuebler, T. K. Banerjee, P. J. Flynn, J. Hickok, G. Morrow
Publikováno v:
Journal of Clinical Oncology. 22:8017-8017
Autor:
A Y, Chang, J P, Kuebler, D C, Tormey, S, Anderson, K J, Pandya, E C, Borden, T E, Davis, D L, Trump
Publikováno v:
Cancer. 57(1)
The combination treatment of mitomycin C (M), vincristine (V), and cisplatin (P) (MVP) in 63 patients with advanced non-small cell lung cancer (NSCLC) were evaluated for their potential synergistic cytotoxicity. The overall response rate was 43% (27/
Publikováno v:
Cancer treatment reports. 64(1)
Autor:
M, Levin, K J, Pandya, J D, Khandekar, J, Horton, J H, Glick, J M, Bennett, F M, Muggia, G, Falkson
Publikováno v:
Cancer treatment reports. 68(12)